Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Therapy for chronic active hepatitis.

L B Seeff, R S Koff

Advances in Internal Medicine

|January 1, 1984

Summary

This summary is machine-generated.

Corticosteroids and azathioprine offer effective treatment for autoimmune chronic active hepatitis (CAH), achieving remission in 65% of cases. However, viral-related CAH lacks effective therapies, with ongoing research for new treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection.

Alimentary pharmacology & therapeutics·2014

Same author

Silymarin use and liver disease progression in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial.

Alimentary pharmacology & therapeutics·2010

Same author

The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy.

Journal of viral hepatitis·2008

Same author

Review article: vaccination and viral hepatitis - current status and future prospects.

Alimentary pharmacology & therapeutics·2007

Same author

Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity.

Oncogene·2006

Same author

Strategies for assessing the long-term consequences of Hepatitis C virus infection.

Minerva gastroenterologica e dietologica·2006

Same journal

Nutrition and nutritional diseases in the Orient.

Advances in internal medicine·2010

Same journal

Nutritional requirements in disease.

Advances in internal medicine·2010

Same journal

Problem of the rhesus antigen in medicine.

Advances in internal medicine·2010

Same journal

Penicillin treatment of subacute bacterial endocarditis.

Advances in internal medicine·2010

Same journal

Physiologic and medical aspects of aviation and deep sea diving.

Advances in internal medicine·2010

Same journal

Progress in the development of insecticides for prevention of insect-borne diseases.

Advances in internal medicine·2010

See all related articles

Area of Science:

Hepatology
Autoimmune Diseases
Viral Hepatitis

Background:

Chronic active hepatitis (CAH) presents diverse etiologies, with limited specific therapeutic options for most forms.
Wilson's disease and drug-induced CAH are rare causes with available management strategies.
Autoimmune CAH is a severe condition necessitating treatment despite significant side effects of current therapies.

Purpose of the Study:

To review the therapeutic landscape for various forms of chronic active hepatitis (CAH).
To evaluate the efficacy and safety of treatment strategies for autoimmune CAH.
To discuss the challenges and future directions in managing viral-related CAH.

Main Methods:

Review of existing literature and clinical data, including Mayo Clinic findings.

Related Experiment Videos

Analysis of treatment outcomes for autoimmune CAH using corticosteroids and azathioprine.

Assessment of emerging experimental therapies for viral-related CAH.

Main Results:

Combination therapy with corticosteroids and azathioprine yields a 65% remission rate in autoimmune CAH within 2-3 years, though relapses occur.
Autoimmune CAH constitutes a minority of cases, with severe forms requiring corticosteroid therapy being even less frequent.
The majority of CAH cases in the US are viral-related, lacking consistently effective treatments.

Conclusions:

Corticosteroids and azathioprine are justified for autoimmune CAH due to its high morbidity and mortality.
While effective for autoimmune CAH, this combination therapy has side effects and requires long-term management.
Effective therapies for the prevalent viral-related CAH remain elusive, with ongoing research focused on combination treatments.